| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |